CTOs on the Move

Alquest

www.alquest.com

 
Alquest has supported numerous international trials and registrations for device clients. Alquest's consulting staff comes from the medical device industry. We've been there. More than half our clients return to us for repeat business. Several device
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.alquest.com
  • 4050 Olson Memorial Hwy Ste 350
    Minneapolis, MN USA 55422
  • Phone: 763.287.3830

Executives

Name Title Contact Details

Similar Companies

Southern Orthopedic Specialist

Southern Orthopedic Specialist is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Phoenix Translations

Phoenix Translations is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cedaron Medical

Cedaron Medical, Inc. is a Davis, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bert Fish Medical Center

Bert Fish Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Bert Fish Medical Center is based in New Smyrna Beach, FL. You can find more information on Bert Fish Medical Center at www.bertfish.com

Clinipace

At Clinipace, a global, full-service contract research organization (CRO), our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment. Our personalized services and solutions, local regulatory expertise and therapeutic leadership are designed to face the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach. In April 2021, Clinipace & dMed merged creating a differentiated mid-size CRO with the largest Asia-Pacific presence. We are proud to have such a strong group of global investors focused on improving healthcare outcomes and giving sponsors a better CRO choice. dMed`s 2019 acquisition of Target Health commenced the process of building a Next Generation global CRO for biotech and pharmaceutical companies. Our investors have invested over $230M to build the next great global CRO. dMed`s acquisition of Target Health in 2019 began dMed`s evolution from a local to global CRO. Target Health LLC is owned by dMedClinical Co. Ltd., a privately held company that is majority owned, operated, managed, and controlled by a U.S. citizen and foreign entities located in the People`s Republic of China. Dr. Lingshi Tan, is the aforementioned U.S. citizen currently residing in Shanghai, China. Dr. Tan moved to Shanghai (from New York) to become Pfizer`s VP of Worldwide Development Operations, and Chairman and General Manager of Pfizer (China) Research & Development Co. Dr. Tan founded dMed in 2016 to satisfy the local demand for a high quality, responsive, flexible CRO.